The regulatory file for coenzyme Q10
Coenzyme Q10 is sold as ubiquinone, CAS 303-98-0, a substance with a long supplement history rather than a vitamin or a mineral. The regulatory file is built from the specification, the lot certificate, the destination's supplement rules, the contaminant limits, the label and the claim review. The buyer's regulatory team confirms the route for the finished product.
Coenzyme Q10 is not a vitamin or a mineral: the EU file rests on national supplement rules, a novel-food check and a claim register with no authorised CoQ10 claim.
What the file contains
The file has four parts: the specification for ubiquinone, the certificate that released the lot, the rules that apply to the finished product in the destination, and the record of how source, process and pack changes are handled. The COA reports the lot, the TDS states the specification and the SDS covers handling. None of them authorises a market entry.
Beyond the certificate, the pack should carry the allergen and GMO statements, the origin record for the manufacturing source, the residual-solvent statement and any declaration the customer needs. If one of those is missing for the lot, name the gap before the order moves. A versioned document list at the front of the folder prevents the quotation, the specification and the certificate from drifting apart.
European Union
Coenzyme Q10 is not a vitamin or a mineral, so it is not one of the substances listed in Annex I of Directive 2002/46/EC for food supplements. It is used as an “other substance with a nutritional or physiological effect”, and that places the detailed conditions in member-state law. Notification duties, maximum levels and the line between a food supplement and a medicinal product have differed between member states, and they can change. A single EU-wide maximum level does not exist for this ingredient.
The novel-food question is separate. Ubiquinone has a history of use in food supplements in the EU, and the Commission's Novel Food Catalogue is a non-binding orientation rather than an authorisation. The catalogue entry, the process and the form have to be checked for the specific material as of the review date. The reduced form, ubiquinol, is a different case: do not assume that the ubiquinone history extends to it, and check the current entry for the exact ubiquinol derivative and its process.
The claim position is clearer than the entry position. As of this review, the EU Register of nutrition and health claims contains no authorised claim for coenzyme Q10. Mechanism language about energy or mitochondria is not an authorised claim, and a claim written for one form does not transfer to the other.
United States
In the United States, coenzyme Q10 is sold as a dietary ingredient under DSHEA. The ingredient has a long supplement history, and the supplier should name the basis it relies on and the document behind it; the buyer then checks that the basis extends to the finished product and the intended use. A USP monograph for ubidecarenone exists, which is useful for a specification but is not a market authorisation.
The Supplement Facts panel names the dietary ingredient and its quantity per serving. A structure/function statement needs substantiation and the DSHEA disclaimer, and it must not be a disease claim. The FDA does not approve dietary supplements or their labels before marketing, so the label review is the brand's responsibility, not a step in the certificate.
United Kingdom
The UK is not one file. Great Britain uses the GB register and GB labelling; Northern Ireland remains under the EU framework, including the EU novel-food and claims position. The delivery address decides which applies, and the buyer's regulatory team should record that decision with the order so the label and the citation can be checked later.
Contaminants and limits
The contaminant panel is a finished-product calculation, not only a drum result. The table below is a starting point for a food-supplement file; the current destination text and the daily dose decide the final limit.
| Parameter | Typical supplement reference | What the file should show |
|---|---|---|
| Lead (Pb) | 3.0 mg/kg in the supplement | Lot result, method, limit and the finished-product calculation |
| Cadmium (Cd) | 1.0 mg/kg in the supplement | Lot result and any category exception that applies |
| Mercury (Hg) | 0.10 mg/kg in the supplement | Lot result and method |
| Arsenic (As) | Customer or market limit | The agreed limit and the method, stated on the certificate |
For the EU, the contaminant limits sit in Regulation (EU) 2023/915 and its amendments, and the food-supplement category has its own entries. Convert the lot result to the finished-product dose before comparing it with the limit: a powder result that passes at one gram a day can fail at a much higher intake. The calculation belongs in the file, not in a covering email.
Claims for coenzyme Q10
The form is part of the claim file. In the EU, as of this review, there is no authorised health claim for coenzyme Q10, and the absence is not repaired by citing a mechanism or a study. In the US, a structure/function statement needs substantiation and the DSHEA disclaimer, and no disease claim is open in either market. This site publishes the specification and makes no health claim.
A label that names ubiquinone and a label that names ubiquinol are making different ingredient declarations. The claim review has to start from the form on the certificate, not from the marketing name. If the claim was written for one form and the order is placed for the other, the file and the label no longer match.
Documents for the file
The buyer's file needs the COA with the HPLC assay on the anhydrous basis, the related-substance chromatogram, the identity tests, loss on drying, the metal panel and the microbiology count. The specification must name ubiquinone and the assay basis; an as-is figure and an anhydrous figure are not interchangeable. Add the source and process description, the TDS, the SDS, allergen and GMO statements, the residual-solvent statement, the stability summary and the novel-food status for the form.
For an oil suspension, add the carrier specification, its peroxide value and the concentration. For a water-dispersible grade, add the carrier, the assay of the premix and the dispersion test. The coenzyme Q10 product page carries the catalog specification, and the identity page explains the analytical evidence.
Checklist before the first order
- Specification version, CAS 303-98-0 and the oxidised form are named.
- COA, TDS, SDS, allergen, GMO, origin and residual-solvent statements are on file.
- The contaminant results are converted to the finished-product dose.
- The label and the claim have been reviewed for the destination.
- The novel-food status of the exact form has been checked as of the review date.
- The source, process and pack are under change control.
- The quotation, the specification and the certificate refer to the same version.
The quality page describes the release file, and the EU regulatory notes collect the framework references. A certificate supports the material; it does not replace the destination route.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation